11/21
04:00 am
zlab
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)
Low
Report
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)
11/18
09:15 am
zlab
Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares
Medium
Report
Zai Lab Announces Anticipated Closing of Public Offering of American Depositary Shares and Full Exercise of Underwriters' Option to Purchase Additional American Depositary Shares
11/15
08:03 am
zlab
Analyst Estimates: Here's What Brokers Think Of Zai Lab Limited (NASDAQ:ZLAB) After Its Third-Quarter Report [Yahoo! Finance]
Medium
Report
Analyst Estimates: Here's What Brokers Think Of Zai Lab Limited (NASDAQ:ZLAB) After Its Third-Quarter Report [Yahoo! Finance]
11/14
07:49 pm
zlab
Zai Lab Announces Pricing of Public Offering of American Depositary Shares [Yahoo! Finance]
Low
Report
Zai Lab Announces Pricing of Public Offering of American Depositary Shares [Yahoo! Finance]
11/14
07:43 pm
zlab
Zai Lab Announces Pricing of Public Offering of American Depositary Shares
Low
Report
Zai Lab Announces Pricing of Public Offering of American Depositary Shares
11/14
09:08 am
zlab
Paratek Pharmaceuticals Announces Completion of U.S. Onshoring Program, Making NUZYRA® (omadacycline) the Only Novel Antibiotic with Domestic Supply and Manufacturing Capabilities [Yahoo! Finance]
Medium
Report
Paratek Pharmaceuticals Announces Completion of U.S. Onshoring Program, Making NUZYRA® (omadacycline) the Only Novel Antibiotic with Domestic Supply and Manufacturing Capabilities [Yahoo! Finance]
11/14
08:02 am
zlab
Zai Lab Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
Medium
Report
Zai Lab Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]
11/13
04:14 pm
zlab
Zai Lab Announces Proposed Public Offering of American Depositary Shares [Yahoo! Finance]
Medium
Report
Zai Lab Announces Proposed Public Offering of American Depositary Shares [Yahoo! Finance]
11/13
04:12 pm
zlab
Zai Lab Announces Proposed Public Offering of American Depositary Shares
Medium
Report
Zai Lab Announces Proposed Public Offering of American Depositary Shares
11/13
02:14 am
zlab
Zai Lab Ltd (ZLAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Path to Profitability [Yahoo! Finance]
Low
Report
Zai Lab Ltd (ZLAB) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Path to Profitability [Yahoo! Finance]
11/12
02:02 pm
zlab
Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
Low
Report
Compared to Estimates, Zai Lab Limited (ZLAB) Q3 Earnings: A Look at Key Metrics [Yahoo! Finance]
11/12
07:23 am
zlab
Zai Lab and argenx announce NMPA approval for sBLA for VYVGART Hytrulo [Yahoo! Finance]
Low
Report
Zai Lab and argenx announce NMPA approval for sBLA for VYVGART Hytrulo [Yahoo! Finance]
11/12
06:30 am
zlab
Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates
Medium
Report
Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates
11/11
07:30 am
zlab
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
Low
Report
Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China
10/29
07:30 am
zlab
Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China
Medium
Report
Zai Lab Reports Positive Topline Data from Phase 3 Bridging Trial Evaluating KarXT for the Treatment of Schizophrenia in China
10/25
12:34 pm
zlab
Zai Lab Limited (NASDAQ: ZLAB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Zai Lab Limited (NASDAQ: ZLAB) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
10/24
05:15 am
zlab
ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung Cancer
High
Report
ZL-1310, an Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC), Demonstrates Promising Objective Response Rates and Safety Profile in Extensive-Stage Small Cell Lung Cancer
10/21
11:07 am
zlab
Zai Lab Limited (NASDAQ: ZLAB) had its price target raised by analysts at JPMorgan Chase & Co. from $38.00 to $44.00. They now have an "overweight" rating on the stock.
Low
Report
Zai Lab Limited (NASDAQ: ZLAB) had its price target raised by analysts at JPMorgan Chase & Co. from $38.00 to $44.00. They now have an "overweight" rating on the stock.
10/18
07:30 am
zlab
Zai Lab Announces Participation in November and December Investor Conferences
Low
Report
Zai Lab Announces Participation in November and December Investor Conferences
10/17
08:00 am
zlab
Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310
Low
Report
Zai Lab to Host Webcast Presentation to Discuss Data from Early Clinical Program Evaluating Its Investigational DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310
10/16
07:30 am
zlab
Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024
Medium
Report
Zai Lab to Announce Third Quarter 2024 Financial Results and Recent Corporate Updates on November 12, 2024
10/15
04:36 pm
zlab
Novocure gets FDA approval for its lung cancer treatment [Seeking Alpha]
Medium
Report
Novocure gets FDA approval for its lung cancer treatment [Seeking Alpha]
10/9
07:00 am
zlab
Zai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024
Low
Report
Zai Lab to Present Data from Phase 1 Trial of ZL-1310, Its Investigational Antibody-Drug Conjugate (ADC) for DLL3+ Solid Tumors, at EORTC-NCI-AACR Symposium (ENA) 2024
9/27
07:18 am
zlab
Zai Lab Limited (ZLAB) Surges 11.1%: Is This an Indication of Further Gains? [Yahoo! Finance]
Low
Report
Zai Lab Limited (ZLAB) Surges 11.1%: Is This an Indication of Further Gains? [Yahoo! Finance]
9/25
04:47 am
zlab
Zai Lab's Growth Strategy And China's Policy Reforms Set Path For Profitability By 2025 [Seeking Alpha]
Medium
Report
Zai Lab's Growth Strategy And China's Policy Reforms Set Path For Profitability By 2025 [Seeking Alpha]